Netherlands· NL-5ecba4c2d9b0

Rapibloc 300 mg poeder voor oplossing voor infusie

A landiolol product containing landiololhydrochloride, registered in Netherlands by Amomed Pharma GmbH. The same ATC class is registered in 15 of our 19 countries.

ATC C07AB14

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about landiololhydrochlorideAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Landiolol is registered in 15 of 19 countries.

Countries holding a registration under ATC C07AB14 (landiolol), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
9 of them publish a price we can compare per daily dose

Search landiolol products by name

Landiolol · ATC C07AB14

15 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Japan
Netherlands
Norwayprice
Polandprice
Spainprice
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)

Active substance: LANDIOLOLHYDROCHLORIDE
Manufacturer: Amomed Pharma GmbH
Country: Netherlands (NL)
ATC code: C07AB14
ATC class: Landiolol
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
116682

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Landiolol in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All landiolol products

Authorised across Europe · EMA

The same active substance is authorised in 25 EEA countries. Names it is sold under:

Austria · Rapibloc
Belgium · Runrapiq
Bulgaria · Рапиблок
Cyprus · Rapibloc
Czechia · Rapibloc
Germany · Rapibloc
Denmark · Rapibloc
Estonia · Raploc
Spain · Rapibloc
Finland · Rapibloc
France · Rapibloc
Greece · Rapibloc
Croatia · Rapibloc
Hungary · Rapibloc
Ireland · Rapibloc
Italy · Landiobloc
Lithuania · Raploc
Latvia · Raploc
Norway · Raploc
Poland · Runrapiq
Portugal · Rapibloc
Romania · Rapibloc
Sweden · Rapibloc
Slovenia · Rapibloc
Slovakia · Rapibloc

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/b8fd5384-0b0e-44a2-a8f4-fef442f6056f
GET /v1/drugs/b8fd5384-0b0e-44a2-a8f4-fef442f6056f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Poeder voor oplossing voor infusie",
  "route": "Intraveneus gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h116682_smpc.pdf",
  "strength": null,
  "atc_label": "Landiolol",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg116682",
  "excipients": [
    "MANNITOL (D-) (E 421)",
    "NATRIUMHYDROXIDE (E 524)"
  ],
  "substances": [
    "LANDIOLOLHYDROCHLORIDE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h116682.pdf",
  "authorised_at": "2016/08/16",
  "procedure_number": "NL/H/3368/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "116682",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about landiolol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console